Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
RAVE Restaurant Group
RAVE
$44.6M
| $455K | ﹤0.01% |
204,122
-7,981
| -4% | -$18.2K |
|
2827
Barclays
BCS
$94.1B
| $454K | ﹤0.01% |
57,586
-782,700
| -93% | -$5.64M |
|
2828
Smartbird Inc
BIRD
$22.3M
| $454K | ﹤0.01% |
18,520
-6,070
| -25% | -$120K |
|
|
CLSD
2829
DELISTED
Clearside Biomedical
CLSD
| $450K | ﹤0.01% |
25,646
+7,427
| +41% | +$106K |
|
2830
GEE Group
JOB
$22.5M
| $449K | ﹤0.01% |
897,392
-64,308
| -7% | -$35K |
|
|
CCRN
2831
DELISTED
Cross Country Healthcare
CCRN
| $448K | ﹤0.01% |
19,786
-165,044
| -89% | -$3.58M |
|
2832
iShares Expanded Tech Sector ETF
IGM
$10.7B
| $448K | ﹤0.01% |
6,000
+1,200
| +25% | +$82K |
|
2833
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $446K | ﹤0.01% |
+8,500
| New | +$432K |
|
2834
Willamette Valley Vineyards
WVVI
$11.9M
| $444K | ﹤0.01% |
82,952
-1,600
| -2% | -$8.58K |
|
|
NEUE
2835
DELISTED
NeueHealth
NEUE
| $444K | ﹤0.01% |
58,163
+1,600
| +3% | +$10.8K |
|
|
ACHL
2836
DELISTED
Achilles Therapeutics
ACHL
| $444K | ﹤0.01% |
498,995
+61,467
| +14% | +$52.7K |
|
|
EMKR
2837
DELISTED
Emcore Corp
EMKR
| $444K | ﹤0.01% |
90,890
+2,810
| +3% | +$12.5K |
|
2838
Schwab Fundamental US Small Company Index ETF
FNDA
$9.38B
| $443K | ﹤0.01% |
16,000
-15,400
| -49% | -$382K |
|
2839
ProShares Short High Yield
SJB
$47.7M
| $443K | ﹤0.01% |
25,700
-25,400
| -50% | -$462K |
|
2840
Gyre Therapeutics
GYRE
$744M
| $439K | ﹤0.01% |
17,085
-22,294
| -57% | -$316K |
|
2841
Franklin Financial Services
FRAF
$280M
| $438K | ﹤0.01% |
+13,897
| New | +$438K |
|
2842
KLX Energy Services
KLXE
$42.3M
| $437K | ﹤0.01% |
38,800
-6,300
| -14% | -$63.8K |
|
|
SEMR
2843
DELISTED
Semrush
SEMR
| $436K | ﹤0.01% |
31,900
-64,800
| -67% | -$640K |
|
2844
USCB Financial Holdings
USCB
$412M
| $435K | ﹤0.01% |
35,500
+17,300
| +95% | +$197K |
|
2845
Nuvectis Pharma
NVCT
$617M
| $432K | ﹤0.01% |
51,800
+26,400
| +104% | +$235K |
|
2846
Chesapeake Utilities
CPK
$3.21B
| $428K | ﹤0.01% |
4,050
-16,200
| -80% | -$1.54M |
|
2847
Palomar
PLMR
$3.45B
| $427K | ﹤0.01% |
7,694
-4,706
| -38% | -$263K |
|
2848
Invesco S&P 500 Pure Growth ETF
RPG
$2.09B
| $426K | ﹤0.01% |
+13,200
| New | +$404K |
|
|
VZLA
2849
Vizsla Silver
VZLA
$1.31B
| $426K | ﹤0.01% |
341,152
+188,299
| +123% | +$205K |
|
2850
Ark Restaurants
ARKR
$20.2M
| $425K | ﹤0.01% |
30,211
-500
| -2% | -$7.61K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.